Please let me know ... I'm trying to understand the observed impact.
Even if they have pushed past 12, statistical significance is based on proabilities and sample size. If I win a coin toss, it could be luck ... if I win two coin tosses, it could still be luck ... if I win 10 coin tosses then it is probably not luck but a two-headed or weighted coin. In the same way, they want to know that the better results of csiplatin is not just random luck but the difference is not enough. google statistical signifiance for a better explanation.
This is saying that the difference is not statistically significant. Thus, there is a good chance the difference is merely random noise.
I believe this is RL capital, but I could not find the paper. If I could confirm this information, I would consider averaging down.
Thanks for the response ... I'll take a look at the paper.
(I wonder why I was red-thumbed for asking a question? Did I say something wrong?)
I'm trying to get my head around this. If, for assumption purposes, the treatment is effective at boosting the immune system to treat cancer, shouldn't the treatment also be effective at boosting the immune system to prevent cancer. Or does the immune system, in these cases, function fundamentally differently?
Its not resolved as the sequester still requires notiation ... that's more important (for VSEC) than taxation rates.
Thanks for the insights ... I'm trying to understand this business a little better. How does the process work to go from distribution deal to hitting the shelves. Do most stores generally stock the products available from distributors or is it still a big hurdle for distributors to get actual orders?
Any knowledge here is certainly appreciated ... really liking the potential here.
Everything revolves around whether or not the company is a fraud. If not, then the company is worth substantially more than the valuation ... if yes, then the company is worth substantially less.
Thus, today's audited results are bullish.
Yes, Q4 wasn't great due to the A/R issue. However, fraud risk is the much more important factor as the valuation is extremely compelling with a PE near 2!! This risk is now reduced substantially with another year of audited results!